Search company, investor...




Angel | Alive

Total Raised


Last Raised

$120K | 6 yrs ago

About ReMoD

ReMoD, formerly MoveAid, is working on rehabilitation devices. The company's first product, called ReMoD, is a device that mimics the function of the sensory center in the brain, giving a user more body control.

Headquarters Location


Missing: ReMoD's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: ReMoD's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing ReMoD

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ReMoD is included in 2 Expert Collections, including Medical Devices.


Medical Devices

8,566 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

ReMoD Frequently Asked Questions (FAQ)

  • What is ReMoD's latest funding round?

    ReMoD's latest funding round is Angel.

  • How much did ReMoD raise?

    ReMoD raised a total of $120K.

  • Who are the investors of ReMoD?

    Investors of ReMoD include Carsten Maschmeyer.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.